Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Biomarkers of Hemolysis, Hemostasis, and Endothelial Activation Are Associated with Clinical Outcomes in Children with Sickle Cell Disease: An 8-Year Prospective Study

Bushra Zucca, Alina Ferster, Laurence Rozen, Anne Demulder, Laurence Dedeken, Anna Vanderfaeillie, Phu-Quoc Le, Denis Noubouossie, Nicolas Lefèvre

Blood (2024) 144 (Supplement 1): 293.

https://doi.org/10.1182/blood-2024-209943

Published: 2024

Journal Articles

Deciphering the Role and Therapeutic Potential of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia

Laurens Van Camp, Jolien Vanhooren, Barbara Depreter, Mattias Hofmans, Inge D'Hont, Christophe Chantrain, Laurence Dedeken, An Van Damme, Anne Uyttebroeck, Tim Lammens, Barbara De Moerloose

Blood (2024) 144 (Supplement 1): 6093.

https://doi.org/10.1182/blood-2024-201130

Published: 2024

Journal Articles

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2024) 144 (Supplement 1): 4954.

https://doi.org/10.1182/blood-2024-204001

Published: 2024

Journal Articles

uRADAR: European Patients Referral Frame to Improve Access to New Drugs and Therapies in Ultra-Rare Anemia Disorders and Severe Hereditary Spherocytosis

Blood (2024) 144 (Supplement 1): 794.

https://doi.org/10.1182/blood-2024-201501

Published: 2024

Journal Articles

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Blood (2023) 142 (Supplement 1): 1052.

https://doi.org/10.1182/blood-2023-190139

Published: 2023

Journal Articles

Outcomes of Children with Sickle Cell Disease Born Outside Belgium Remain Different Compared to Those Born in Belgium Despite Similar Management

Emily Antonovics, Alina Ferster, Laurence Dedeken, Andrea Nebbioso, Gaelle Mpawenayo, Laure Kornreich, Catherine Heijmans, Safiatou Diallo, Pauline Mazilier, Pierluigi Calo, Christine Devalck, Phu-Quoc Le

Blood (2023) 142 (Supplement 1): 3885.

https://doi.org/10.1182/blood-2023-188999

Published: 2023

Journal Articles

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19

Pablo Velasco, Filomena Longo, Andrea Piolatto, Eduardo J. Bardón-Cancho, Beatriz Ponce-Salas, Pagona Flevari, Ersi Voskaridou, Bart J. Biemond, Erfan Nur, Polyxeni Delaporta, Tatiana Besse-Hammer, Anna Ruiz-Llobet, Simona Raso, Anna Spasiano, Maria Elena Guerzoni, David Beneitez-Pastor, Laurence Dedeken, Alessia Pepe, Rosamaria Rosso, Joachim B. Kunz, Mariane de Montalembert, Saveria Campisi, Andreas Glenthøj, Paula Gonzalez Urdiales, Fleur Samantha Benghiat, Marie-Agnès Azerad, Christopher J. Saunders, Teresa Ferreira Faria, Tommaso Casini, Sabrina Bagnato, Ann Van de Velde, Veerle Labarque, Elisa Bertoni, An Van Damme, Michael D. Diamantidis, Roberta Russo, Eftichia Stiakaki, Alessandra Quota, Soteroula Christou, Maria Jose Teles, Ioannis Lafiatis, Jean-Louis Kerkhoffs, María Argüello Marina, Mikael Lorite, Alexis Rodriguez, Achille Iolascon, Ali T. Taher, Raffaella Colombatti, Noemi Roy, Maria Del Mar Mañú Pereira

Blood (2021) 138 (Supplement 1): 4058.

https://doi.org/10.1182/blood-2021-147236

Published: 2021

Journal Articles

Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry

Sarah Wambacq, Beatrice Gulbis, Fleur Samantha Benghiat, Bénédicte Brichard, Bruwier Annelyse, Laurence Dedeken, Bram De Wilde, Marie-Françoise Dresse, Andre Efira, Catherine Heijmans, Veerle Labarque, Phu-Quoc Le, Philip Maes, Pierre Philippet, An Van Damme, Anna Vanderfaeillie, Alina Ferster

Blood (2021) 138 (Supplement 1): 4171.

https://doi.org/10.1182/blood-2021-145403

Published: 2021

Journal Articles

Did the Outcome of Sicke Cell Disease Babies Screened at Birth Improved from 2000? a Single Center Experience

Clemence Peresse, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD PhD, Laurence Rozen, Beatrice Gulbis, MD PhD, Sarah Wambacq, Alina Ferster, MD

Blood (2019) 134 (Supplement_1): 4847.

https://doi.org/10.1182/blood-2019-130294

Published: 2019

Journal Articles

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Geoffrey Bourg, MD, Laurence Dedeken, MD, Phu-Quoc Le, MD PhD, Laurence Rozen, Safiatou Diallo, MD, Sabine Amah, MD, Christine Devalck, MD, Catherine Heijmans, MD, Laurence Hanssens, MD, Rossana Pavone, MD, Malou Ngalula Mujinga, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 1085.

https://doi.org/10.1182/blood-2018-99-118373

Published: 2018

Journal Articles

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

Phu-Quoc Le, MD PhD, Beatrice Gulbis, MD PhD, Laurence Dedeken, MD, Laurence Rozen, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Fleur Samantha Benghiat, Andre Efira, MD, Marie-Françoise Dresse, MD PhD, Alina Ferster, MD

Blood (2018) 132 (Supplement 1): 4923.

https://doi.org/10.1182/blood-2018-99-119319

Published: 2018

Journal Articles

No Impact of Pharmacokinetics Profiles on the Clinical and Biological Response to Hydroxyurea in Children with Sickle Cell Disease

Maria Karimi, MD, Anar Rodriguez Cheang, Laurence Dedeken, MD, Phu-Quoc Lê, MD, Laurence Rozen, Malou Ngalula Mujinga, Bernard Wenderickx, Alina Ferster, MD

Blood (2017) 130 (Supplement 1): 3549.

https://doi.org/10.1182/blood.V130.Suppl_1.3549.3549

Published: 2017

Journal Articles

Safe Deep Sedation with Midazolam and Propofol for Cerebral MRI in Young Children with Sickle Cell Disease Is Safe: A Single Center Experience in Belgium

Cécile Callewaert, MD, Laurence Dedeken, MD, Françoise De Groote, MD, Laurence Rozen, Phu-Quoc Lê, MD, Sophie Huybrechts, MD, Safiatou Diallo, MD, Christine Devalck, MD, Catherine Heijmans, MD, Andrée De Ville, MD, Alina Ferster, MD

Blood (2016) 128 (22): 1324.

https://doi.org/10.1182/blood.V128.22.1324.1324

Published: 2016

Journal Articles

Successful Transition from Paediatric to Adult Care in Sickle Cell Disease: An Experience in a Belgian Center

Tracy Vandergraesen, MD, Laurence Dedeken, MD, Andre Efira, MD PhD, Phu Quoc Lê, MD, Sophie Huybrechts, MD, Safiatou Diallo, MD, Christine Devalck, MD, Catherine Heijmans, MD, Marie-Agnes Azerad, MD, Alina Ferster, MD

Blood (2016) 128 (22): 2495.

https://doi.org/10.1182/blood.V128.22.2495.2495

Published: 2016

Journal Articles

Excellent Outcome in Pediatric AML with Response Guided Chemotherapy without Allogeneic HSCT in First Complete Remission: Results from Protocol DB-AML01

Eveline de Bont, MD PhD, Ardine Reedijk, MSc, Tim Lammens, PhD, Valerie de Haas, MD PhD, Barbara Denys, PhD, Laurence Dedeken, MD, Marry van den Heuvel, MD PhD, Maroeska Loo, MD PhD, Anne Uyttebroeck, An Vandamme, MD PhD, Jutte VanderWerff-ten Bosch, MD PhD, Jozsef Zsiros, Gertjan J.L. Kaspers, MD PhD, Barbara Moerloose, MD PhD

Blood (2015) 126 (23): 2506.

https://doi.org/10.1182/blood.V126.23.2506.2506

Published: 2015

Journal Articles

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Phu-Quoc Lê, MD, Alina Ferster, MD, Laurence Dedeken, MD, Laurence Rozen, PharmD, Christiane Vermylen, MD PhD, Anna Vanderfaeillie, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Catherine Heijmans, MD, Marie-Françoise Dresse, MD PhD, André Efira, MD, Samantha Benghiat, MD PhD, Sophie Dupont, MD, Beatrice Gulbis, MD PhD

Blood (2014) 124 (21): 4935.

https://doi.org/10.1182/blood.V124.21.4935.4935

Published: 2014

Journal Articles

Clinical Benefit and Costs’ Evaluation of Erythocytapheresis Compared to Manual Exchange Transfusion for Children with Sickle Cell Disease: A Single Center Experience

Laurence Dedeken, MD, Phu Quoc Lê, MD, Laurence Rozen, PharmD, Hanane El Kenz, MD, Sophie Huybrechts, MD, Christine Devalck, MD, Delphine Sauvage, MD, Catherine Heijmans, MD, Alina Ferster, MD

Blood (2014) 124 (21): 4091.

https://doi.org/10.1182/blood.V124.21.4091.4091

Published: 2014

Journal Articles

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Phu-Quoc Lê, MD, Laurence Dedeken, MD, Beatrice Gulbis, MD, PhD, Christiane Vermylen, MD, PhD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christine Devalck, MD, Sophie Huybrechts, MD, Samantha Benghiat, MD, André Efira, MD, Marie-Francoise Dresse, MD, Sophie Dupont, MD, Alina Ferster, MD

Blood (2013) 122 (21): 2231.

https://doi.org/10.1182/blood.V122.21.2231.2231

Published: 2013

Journal Articles

Thrombin Generation Test During Asparaginase Treatment In Children With Acute Lymphoblastic Leukemia

Laurence Rozen, PharmD, Denis F Noubouossie, MD, Laurence Dedeken, MD, Sophie Huybrechts, MD, Phu-Quoc Le, MD, Alina Ferster, MD, Anne Demulder, MD, PHD

Blood (2013) 122 (21): 2367.

https://doi.org/10.1182/blood.V122.21.2367.2367

Published: 2013

Journal Articles

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Phu-Quoc Le, MD, Beatrice Gulbis, MD, PhD, Laurence Dedeken, MD, Anna Vanderfaeillie, MD, Catherine Heijmans, MD, Christiane Vermylen, MD, PhD, Sophie Huybrechts, MD, Christine Devalck, MD, Frederic Cotton, PhD, Ba Cuong Nguyen, Françoise Vertongen, MD, PhD, Malou Ngalula, Alina Ferster, MD

Blood (2012) 120 (21): 4757.

https://doi.org/10.1182/blood.V120.21.4757.4757

Published: 2012

NARROW

Biomarkers of Hemolysis, Hemostasis, and Endothelial Activation Are Associated with Clinical Outcomes in Children with Sickle Cell Disease: An 8-Year Prospective Study

Deciphering the Role and Therapeutic Potential of Macrophage Marker CD68 in Pediatric Acute Myeloid Leukemia

Durable Clinical Benefits with Exagamglogene Autotemcel for Severe Sickle Cell Disease

uRADAR: European Patients Referral Frame to Improve Access to New Drugs and Therapies in Ultra-Rare Anemia Disorders and Severe Hereditary Spherocytosis

Exagamglogene Autotemcel for Severe Sickle Cell Disease

Outcomes of Children with Sickle Cell Disease Born Outside Belgium Remain Different Compared to Those Born in Belgium Despite Similar Management

ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19

Factors Influencing Change in MCV and Age at Transplantation in the Belgian Sickle Cell Disease Registry

Did the Outcome of Sicke Cell Disease Babies Screened at Birth Improved from 2000? a Single Center Experience

Improvement of the Six-Minute Walk Test in Children with Sickle Cell Disease over Time

Is There an Increase in Sickle Cell Related Events Among the Adult Belgian Population?

No Impact of Pharmacokinetics Profiles on the Clinical and Biological Response to Hydroxyurea in Children with Sickle Cell Disease

Safe Deep Sedation with Midazolam and Propofol for Cerebral MRI in Young Children with Sickle Cell Disease Is Safe: A Single Center Experience in Belgium

Successful Transition from Paediatric to Adult Care in Sickle Cell Disease: An Experience in a Belgian Center

Excellent Outcome in Pediatric AML with Response Guided Chemotherapy without Allogeneic HSCT in First Complete Remission: Results from Protocol DB-AML01

Genetic Counseling in Hemoglobin SC Disease: Data from the Belgian Registry

Clinical Benefit and Costs’ Evaluation of Erythocytapheresis Compared to Manual Exchange Transfusion for Children with Sickle Cell Disease: A Single Center Experience

Low Sickle Cell Disease Mortality In Belgium and Benefit From Hydroxyurea Therapy

Thrombin Generation Test During Asparaginase Treatment In Children With Acute Lymphoblastic Leukemia

Newborn Screening for Sickle Cell Disease in Brussels, a Program with an Ongoing Clinical Outcome Improvement

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only